Viemed Q2 2024 revenue hits record $55.0M, up 27% YoY; Adjusted EBITDA up 31%

VIEMED HEALTHCARE, INC.

2024-Q2 EPS reported $0.08 revenue$105,558,000

Net revenues $55.0M (record), up 27% YoY and 9% sequential from Q1 2024.
Net income $1.5M for Q2 2024.
Adjusted EBITDA $12.8M, a 31% increase over Q2 2023.
Company reports strong growth in respiratory care and home medical equipment services.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.